4.7 Article

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations

Journal

BLOOD
Volume 139, Issue 12, Pages 1850-1862

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2021011921

Keywords

-

Categories

Funding

  1. Japan Agency for Medical Research (AMED) [JP17cm0106525, JP16ck0106129, JP19ck0106331, JP20ck0106607, JP19ck0106253, JP20cm0106472, JP16kk0205005]
  2. P-Direct, Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [JP15cm0106055]
  3. JSPS KAKENHI [18K16103, 18H02835, 20K08723]
  4. Princess Takamatsu Cancer Research Fund [16-24820]
  5. Takeda Science Foundation
  6. Daiichisankyo Foundation of Life Science
  7. MEXT as Program for Promoting Researches on the Supercomputer Fugaku''
  8. RIKEN Center for Computational Science [hp200138]
  9. Grants-in-Aid for Scientific Research [20K08723, 18K16103, 18H02835] Funding Source: KAKEN

Ask authors/readers for more resources

This study aimed to improve the understanding of the biological characteristics of adult B-ALL, improve disease stratification, and identify molecular targets. The study identified two novel subtypes with poor prognosis, which were more prevalent in adults compared to children.
The genetic basis of leukemogenesis in adults with B-cell acute lymphoblastic leukemia (B-ALL) is largely unclear, and its clinical outcome remains unsatisfactory. This study aimed to advance the understanding of biological characteristics, improve disease stratification, and identify molecular targets of adult B-ALL. Adolescents and young adults (AYA) (15 to 39 years old, n = 193) and adults (40 to 64 years old, n = 161) with Philadelphia chromosome-negative (Ph-) B-ALL were induded in this study. Integrated transcriptomic and genetic analyses were used to classify the cohort into defined subtypes. Of the 323 cases included in the RNA sequencing analysis, 278 (86.1%) were classified into 18 subtypes. The ZNF384 subtype (22.6%) was the most prevalent, with 2 novel subtypes (CDX2-high and IDH1/2-mut) identified among cases not assigned to the established subtypes. The CDX2-high subtype (3.4%) was characterized by high expression of CDX2 and recurrent gain of chromosome 1q. The IDH1/2-mut subtype (1.9%) was defined by IDHI R132C or IDH2 R140Q mutations with specific transcriptional and high-methylation profiles. Both subtypes showed poor prognosis and were considered inferior prognostic factors independent of clinical parameters. Comparison with a previously reported pediatric B-ALL cohort (n = 1003) showed that the frequencies of these subtypes were significantly higher in AYA/adults than in children. We delineated the genetic and transcriptomic landscape of adult B-ALL and identified 2 novel subtypes that predict poor disease outcomes. Our findings highlight the age-dependent distribution of subtypes, which partially accounts for the prognostic differences between adult and pediatric B-ALL.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available